Abstract Background There is a paucity of studies comparing postoperative thromboembolic and major bleeding complications following perioperative interruption of the direct oral anticoagulants (DOACs) and vitamin K antagonists (VKAs). Objective/Methods We conducted a retrospective cohort study to compare postoperative thromboembolic and major bleeding outcomes following perioperative interruption of DOACs and VKAs in patients with atrial fibrillation. The primary efficacy and safety outcomes were the 30‐day postoperative rates of arterial thromboembolic events (ATEs) and major bleeding, respectively. The secondary outcomes included the 30‐day rates of clinically relevant nonmajor bleeding (CRNMB) and overall mortality. Thromboembolic, major...
Perioperative management of patients treated with the non-vitamin K antagonist oral anticoagulants i...
Introduction The Perioperative Anticoagulation Use for Surgery Evaluation (PAUSE) Study assessed a ...
Purpose: As the number of patients taking vitamin K antagonists (VKA) is growing, the clinician is i...
Background The benefit of periprocedural bridging with low-molecular-weight heparin (LMWH) in patien...
Importance:Patients with atrial fibrillation (AF) who use a direct oral anticoagulant (DOAC) and req...
Abstract Background There is a lack of data on anticoagulation requirements during ablation of atria...
Importance: Patients with atrial fibrillation (AF) who use a direct oral anticoagulant (DOAC) and re...
Background — The benefit of preoperative bridging in surgical patients with continuous anticoagulant...
Introduction: The perioperative management of patients who are taking a direct oral anticoagulant (D...
Abstract Background Post-operative atrial fibrillation (POAF) is the most common complication after ...
Abstract Background The aim of this prospective study was to investigate the occurrence and severity...
OBJECTIVE: The recommendations for the management of direct oral anticoagulants (DOACs) in oral surg...
AIMS: Although a recent expert consensus statement has recommended periprocedural uninterrupted (UI)...
Anticoagulants are widely used, especially in the elderly, for the prevention and treatment of throm...
OBJECTIVE: Despite increasing use of direct oral anticoagulants (DOACs), guidelines for their periop...
Perioperative management of patients treated with the non-vitamin K antagonist oral anticoagulants i...
Introduction The Perioperative Anticoagulation Use for Surgery Evaluation (PAUSE) Study assessed a ...
Purpose: As the number of patients taking vitamin K antagonists (VKA) is growing, the clinician is i...
Background The benefit of periprocedural bridging with low-molecular-weight heparin (LMWH) in patien...
Importance:Patients with atrial fibrillation (AF) who use a direct oral anticoagulant (DOAC) and req...
Abstract Background There is a lack of data on anticoagulation requirements during ablation of atria...
Importance: Patients with atrial fibrillation (AF) who use a direct oral anticoagulant (DOAC) and re...
Background — The benefit of preoperative bridging in surgical patients with continuous anticoagulant...
Introduction: The perioperative management of patients who are taking a direct oral anticoagulant (D...
Abstract Background Post-operative atrial fibrillation (POAF) is the most common complication after ...
Abstract Background The aim of this prospective study was to investigate the occurrence and severity...
OBJECTIVE: The recommendations for the management of direct oral anticoagulants (DOACs) in oral surg...
AIMS: Although a recent expert consensus statement has recommended periprocedural uninterrupted (UI)...
Anticoagulants are widely used, especially in the elderly, for the prevention and treatment of throm...
OBJECTIVE: Despite increasing use of direct oral anticoagulants (DOACs), guidelines for their periop...
Perioperative management of patients treated with the non-vitamin K antagonist oral anticoagulants i...
Introduction The Perioperative Anticoagulation Use for Surgery Evaluation (PAUSE) Study assessed a ...
Purpose: As the number of patients taking vitamin K antagonists (VKA) is growing, the clinician is i...